» Authors » Kathleen Herkommer

Kathleen Herkommer

Explore the profile of Kathleen Herkommer including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 87
Citations 1466
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Meissner V, Dinkel A, Kron M, Schiele S, Jahnen M, Lakes J, et al.
J Behav Med . 2025 Mar; PMID: 40042752
Cancer worry and risk perception are relevant psychological factors that influence preventive health behaviors. Therefore, a thorough understanding of the factors that impact their occurrence and manifestation is critical. The...
2.
Meissner V, Imhof K, Jahnen M, Lunger L, Dinkel A, Schiele S, et al.
J Natl Compr Canc Netw . 2024 Dec; 23(1. PMID: 39662044
Background: Frailty is emerging as an important determinant for quality of life (QoL) and emotional health in older patients with cancer, and specifically in long-term prostate cancer survivors, but quantitative...
3.
Jahnen M, Rechberger A, Meissner V, Schiele S, Schulwitz H, Gschwend J, et al.
Andrology . 2024 Nov; PMID: 39545565
Background: Vasectomy is a safe and effective form of contraception. However, fear of altered sexual function is still associated with vasectomy in many men. Objectives: To assess the prevalence of...
4.
Kirchhoff F, Hubner R, Kron M, Schiele S, Schulwitz H, Peter C, et al.
J Sex Med . 2024 Nov; 22(1):36-42. PMID: 39496552
Background: The Erectile Function Domain of the International Index of Erectile Function (IIEF6) is inaccurate in assessing erectile function in men who are not practicing sexual intercourse. Improvement through a...
5.
Klorek T, Schlichte A, Peter C, Jahnen M, Dinkel A, Schiele S, et al.
Urologie . 2024 Sep; 64(1):29-37. PMID: 39304562
Background: Radical prostatectomy (RP) is one of the most common therapeutic strategies for treating localized prostate cancer (PCa). Currently, the significance of postoperative functional limitations for affected patients in the...
6.
Krilaviciute A, Kaaks R, Seibold P, De Vrieze M, Lakes J, Radtke J, et al.
Eur Urol . 2024 May; 86(6):493-500. PMID: 38749854
Background: Risk-adjusted screening for prostate cancer (PCa) aims to reduce harms by less frequent retesting, especially in men at a low risk of PCa. Definitions of low risk are based...
7.
Jahnen M, Hausler T, Meissner V, Ankerst D, Kattan M, Sauter A, et al.
World J Urol . 2024 May; 42(1):290. PMID: 38702557
Purpose: mpMRI is routinely used to stratify the risk of clinically significant prostate cancer (csPCa) in men with elevated PSA values before biopsy. This study aimed to calculate a multivariable...
8.
Jahnen M, Amiel T, Kirchoff F, Buchler J, Herkommer K, Rothe K, et al.
World J Urol . 2024 Apr; 42(1):260. PMID: 38664275
Purpose: The recent restriction on the use of fluoroquinolones for prophylaxis by the European Commission has left a gap in clear recommendations for practical antibiotic prophylaxis (PAP) for transrectal prostate...
9.
Boschheidgen M, Albers P, Schlemmer H, Hellms S, Bonekamp D, Sauter A, et al.
Eur Urol . 2023 Oct; 85(2):105-111. PMID: 37863727
Background: Magnetic resonance imaging (MRI) has been suggested as a tool for guiding biopsy recommendations in prostate cancer (PC) screening. Objective: To determine the performance of multiparametric MRI (mpMRI) in...
10.
Krilaviciute A, Becker N, Lakes J, Radtke J, Kuczyk M, Peters I, et al.
Eur Urol Oncol . 2023 Oct; 6(6):566-573. PMID: 37806841
Background: Annual digital rectal examination (DRE) is recommended as a stand-alone screening test for prostate cancer (PCa) in Germany for 45+ yr olds. DRE diagnostic performance in men as young...